Medical News

RSS

KYTHERA completes enrollment in ATX-101 Phase III trials for reduction of submental fat

KYTHERA Biopharmaceuticals, Inc. today announced the completion of enrollment in two pivotal U.S. and Canadian Phase III clinical trials of ATX-101, a potential first-in-class injectable facial aesthetic drug under clinical investigation for the reduction of submental fat, which commonly presents as an undesirable "double chin." KYTHERA expects to release top-line results in mid-2013.

4 Sep 2012

Biokine, BioLineRx sign license agreement to develop and commercialize BL-8040 for AML

BioLineRx Ltd., a biopharmaceutical drug development company, announced today that it has signed an exclusive, worldwide license agreement with Biokine Therapeutics Ltd., a Clal Biotechnology Industries portfolio company, for the development and commercialization of BL-8040 (formerly BKT-140), a Phase II ready drug candidate for the treatment of acute myeloid leukemia (AML), as well as other types of hematological cancer.

4 Sep 2012

Net Health Systems acquires Wound Care Strategies

Net Health Systems, the leading provider of clinical information systems for the rapidly growing field of wound care, announced today the acquisition of Wound Care Strategies, Inc. developers of the TPS Electronic Medical Record software for wound care providers.

4 Sep 2012

First Edition: September 4, 2012

Today's early morning highlights from the major news organizations, including previews of the Democratic convention and a New York Times analysis of how the Obama and Romney campaigns vary on Medicaid policy.

4 Sep 2012

EC grants marketing authorization for Pfizer’s INLYTA to treat renal cell carcinoma

Pfizer Inc. announced today that the European Commission (EC) has granted marketing authorization for INLYTA (axitinib) for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

4 Sep 2012

Ultrastable RNA nanoparticles may help treat cancer and viral infections

A new study by University of Kentucky researchers shows promise for developing ultrastable RNA nanoparticles that may help treat cancer and viral infections by regulating cell function and binding to cancers without harming surrounding tissue.

4 Sep 2012

Scientists discover new anti-cancer and anti-metastatic molecule

A new molecule with anti-cancer and anti-metastatic properties has been discovered by teams from CNRS, CEA, the Institut Curie and Inserm, in collaboration with Australian and British researchers.

4 Sep 2012

Meijer offers generic Lipitor for free to help families be heart healthy

In an effort to help families be heart healthy, this week Midwest retailer Meijer began offering the generic substitute for Lipitor (atorvastatin calcium) for free in all 199 Meijer pharmacies.

4 Sep 2012

A-kinase anchoring proteins influence levels of glucose in the body

Scientists from the United States and Sweden have discovered a new control point that could be important as a drug target for the treatment of diabetes and other metabolic diseases.

4 Sep 2012

GE Healthcare introduces KUBio factory

GE Healthcare, the healthcare business of GE, today introduced KUBio, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money.

4 Sep 2012

Converting blood cells to a stem cell state: an interview with Elias Zambidis, M.D., Ph.D.

The primitive stem cell state we created is called an “induced pluripotent stem cell” (iPSC). iPSC are a new, unique, and artificially-created type of stem cell that were first described in 2006 by a Japanese scientist named Shinya Yamanaka.

4 Sep 2012

Study finds 93% reduction in head injuries related to cycling among Swedish children

Since 1978 the rate of hospitalisations of Swedish children because of head injuries related to cycling has been reduced by 93%. This means that a large number of children, instead of being severely disabled, have been able to live normal lives.

4 Sep 2012

New health insurance product from ICICI Lombard

ICICI Lombard General Insurance Company Ltd., the country's largest private sector general insurance company, announced the launch of a unique health insurance product called "ICICI Lombard Complete Health Insurance".

4 Sep 2012

FDA approves Novartis’ Exelon Patch to treat mild to moderate AD

The US Food and Drug Administration has approved a higher dose of Exelon Patch (rivastigmine transdermal system) for the treatment of people with mild to moderate Alzheimer's disease.

4 Sep 2012

Data from ESTEVE’s S1RA E-52862 Phase I trial programme on pain

ESTEVE announces the recent publication of data from the Phase I clinical trial programme of a novel, highly potent and selective, once-daily, S1RA E-52862, developed by the ESTEVE R&D team, in the British Journal of Clinical Pharmacology.

4 Sep 2012

Medical imaging not a driver of escalating Medicare costs

According to a study in the Sept. issue of the Journal of the American College of Radiology, overall non-invasive diagnostic imaging (NDI) costs to Medicare Part B dropped 21 percent from 2006 to 2010. The study reveals that medical imaging is not a driver of escalating Medicare costs.

4 Sep 2012

Accusations reflect conflicting beliefs about care, says commentary in Mayo Clinic Proceedings

In a recent survey of palliative care medicine practitioners, nearly three quarters of the sample reported having been "humorously" accused of promoting death; for example, being called "Dr. Death." Most of the remarks came from fellow physicians and other health care professionals. At the same time, the survey found that a third of investigations into accusations of murder or euthanasia against physicians are instigated by fellow members of the health care team.

4 Sep 2012

Study finds increase in HIV treatment use in the U.S.

Between 2000 and 2008, the proportion of HIV-infected patients in the U.S. receiving effective treatment known as highly active antiretroviral therapy (HAART) increased, and HIV-infected patients appeared to be less infectious and have healthier immune systems at death, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

4 Sep 2012

Regional PACS networks may be useful in reducing cost and radiation exposure associated with trauma

According to a study in the Sept. issue of the Journal of the American College of Radiology, using a combination of the Internet and compact discs (CD) to transfer images during inter-hospital transfer is associated with much lower repeat imaging rates, suggesting that regional PACS networks may be useful for reducing cost and radiation exposure associated with trauma.

4 Sep 2012

Morphological changes occur rapidly in response to cardiac injury

Cardiac injury leads to significant structural changes in the heart, including enlargement, excess formation of fibrous growth tissue, and abnormalities of the coronary vasculature. While associated factors have been targeted for therapeutic intervention, the results have been conflicting. Most studies have investigated these changes after six days of injury. However, advanced stages of remodeling have already begun by day seven following injury.

4 Sep 2012